Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |